Statistics for The prevalence and associated risks of concurrent use of cholinestrerase inhibitors, antipsychotic and/or anticholinergic medications in patients with alzheimer's disease
Total visits
| views | |
|---|---|
| The prevalence and associated risks of concurrent use of cholinestrerase inhibitors, antipsychotic and/or anticholinergic medications in patients with alzheimer's disease | 1 |
Total visits per month
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| ucalgary_2008_supina_alison lorraine_559982.pdf | 29 |
Top country views
| views | |
|---|---|
| Canada | 1 |
Top city views
| views | |
|---|---|
| Calgary | 1 |